CN1160354C - 合成氯嘌呤中间体的方法 - Google Patents

合成氯嘌呤中间体的方法 Download PDF

Info

Publication number
CN1160354C
CN1160354C CNB988121522A CN98812152A CN1160354C CN 1160354 C CN1160354 C CN 1160354C CN B988121522 A CNB988121522 A CN B988121522A CN 98812152 A CN98812152 A CN 98812152A CN 1160354 C CN1160354 C CN 1160354C
Authority
CN
China
Prior art keywords
formula
compound
acid
ims
alkali
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB988121522A
Other languages
English (en)
Chinese (zh)
Other versions
CN1281457A (zh
Inventor
Mf
M·F·琼斯
C·J·瓦利斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN1281457A publication Critical patent/CN1281457A/zh
Application granted granted Critical
Publication of CN1160354C publication Critical patent/CN1160354C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CNB988121522A 1997-10-14 1998-10-14 合成氯嘌呤中间体的方法 Expired - Lifetime CN1160354C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721780.6A GB9721780D0 (en) 1997-10-14 1997-10-14 Process for the synthesis of chloropurine intermediates
GB9721780.6 1997-10-14

Publications (2)

Publication Number Publication Date
CN1281457A CN1281457A (zh) 2001-01-24
CN1160354C true CN1160354C (zh) 2004-08-04

Family

ID=10820547

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988121522A Expired - Lifetime CN1160354C (zh) 1997-10-14 1998-10-14 合成氯嘌呤中间体的方法

Country Status (43)

Country Link
US (1) US6646125B1 (enExample)
EP (1) EP1023292B1 (enExample)
JP (1) JP4531250B2 (enExample)
KR (1) KR100543845B1 (enExample)
CN (1) CN1160354C (enExample)
AP (1) AP1182A (enExample)
AR (1) AR014921A1 (enExample)
AT (1) ATE249461T1 (enExample)
AU (1) AU738462B2 (enExample)
BG (1) BG64597B1 (enExample)
BR (1) BR9813048B1 (enExample)
CA (1) CA2306958C (enExample)
CO (1) CO4980899A1 (enExample)
CZ (1) CZ294482B6 (enExample)
DE (1) DE69818084T2 (enExample)
DK (1) DK1023292T3 (enExample)
EA (1) EA003183B1 (enExample)
EE (1) EE04059B1 (enExample)
EG (1) EG21730A (enExample)
ES (1) ES2205553T3 (enExample)
GB (1) GB9721780D0 (enExample)
GE (1) GEP20022679B (enExample)
HR (1) HRP20000216B1 (enExample)
HU (1) HUP0003984A3 (enExample)
ID (1) ID24927A (enExample)
IL (1) IL135323A (enExample)
IN (1) IN184590B (enExample)
IS (1) IS2195B (enExample)
MA (1) MA24676A1 (enExample)
MY (1) MY127470A (enExample)
NO (1) NO325030B1 (enExample)
NZ (1) NZ503679A (enExample)
OA (1) OA11370A (enExample)
PE (1) PE121899A1 (enExample)
PL (1) PL188477B1 (enExample)
PT (1) PT1023292E (enExample)
RS (1) RS49710B (enExample)
SK (1) SK285331B6 (enExample)
TR (1) TR200000976T2 (enExample)
TW (1) TW436488B (enExample)
UA (1) UA54550C2 (enExample)
WO (1) WO1999019327A1 (enExample)
ZA (1) ZA989338B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284594B6 (sk) 1997-11-27 2005-07-01 Lonza Ag Spôsob výroby derivátov aminoalkoholov a ich soli
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
GB0320738D0 (en) * 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
CN100465174C (zh) * 2006-06-13 2009-03-04 中国科学院上海有机化学研究所 制备光学纯阿巴卡韦的方法
KR101109476B1 (ko) * 2009-06-26 2012-01-31 현대제철 주식회사 실린더 교체용 지그장치
NZ627827A (en) 2010-01-27 2016-02-26 Viiv Healthcare Co Antiviral combinations involving (3s, 11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
CN104672239A (zh) * 2013-11-26 2015-06-03 上海迪赛诺化学制药有限公司 一种采用一锅法制备阿巴卡韦式v中间体的工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ コムパニ− 神経弛緩剤、1‐フルオロフェニルブチル‐4‐(5‐ハロ‐2‐ピリミジニル)ピペラジン誘導体
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
JP2793825B2 (ja) * 1988-01-20 1998-09-03 リージヤンツ・オブ・ザ・ユニバーシテイ・オブ・ミネソタ ジデオキシジデヒドロ炭素環式ヌクレオシド
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu

Also Published As

Publication number Publication date
CZ20001367A3 (cs) 2000-10-11
HUP0003984A3 (en) 2002-12-28
US6646125B1 (en) 2003-11-11
HUP0003984A2 (hu) 2001-04-28
BG64597B1 (bg) 2005-08-31
UA54550C2 (uk) 2003-03-17
PL188477B1 (pl) 2005-02-28
KR20010015744A (ko) 2001-02-26
EE200000162A (et) 2001-04-16
IL135323A (en) 2004-07-25
BR9813048A (pt) 2000-08-15
SK285331B6 (sk) 2006-11-03
CA2306958A1 (en) 1999-04-22
PL339904A1 (en) 2001-01-15
AU738462B2 (en) 2001-09-20
IS2195B (is) 2007-01-15
IL135323A0 (en) 2001-05-20
YU20200A (sh) 2003-02-28
NO20001896L (no) 2000-06-13
EA003183B1 (ru) 2003-02-27
WO1999019327A1 (en) 1999-04-22
ZA989338B (en) 2000-04-13
ES2205553T3 (es) 2004-05-01
SK5362000A3 (en) 2001-03-12
JP4531250B2 (ja) 2010-08-25
HRP20000216B1 (en) 2002-08-31
OA11370A (en) 2004-01-27
EE04059B1 (et) 2003-06-16
DE69818084D1 (de) 2003-10-16
NZ503679A (en) 2002-09-27
EP1023292B1 (en) 2003-09-10
NO20001896D0 (no) 2000-04-12
AU9547698A (en) 1999-05-03
EG21730A (en) 2002-02-27
MY127470A (en) 2006-12-29
PE121899A1 (es) 1999-12-20
GEP20022679B (en) 2002-04-25
AP2000001790A0 (en) 2000-06-30
EP1023292A1 (en) 2000-08-02
DE69818084T2 (de) 2004-07-15
HRP20000216A2 (en) 2000-08-31
BR9813048B1 (pt) 2010-07-13
NO325030B1 (no) 2008-01-21
HK1027807A1 (en) 2001-01-23
CN1281457A (zh) 2001-01-24
EA200000318A1 (ru) 2000-12-25
CZ294482B6 (cs) 2005-01-12
GB9721780D0 (en) 1997-12-10
DK1023292T3 (da) 2003-11-10
JP2001519432A (ja) 2001-10-23
MA24676A1 (fr) 1999-07-01
TR200000976T2 (tr) 2000-11-21
AR014921A1 (es) 2001-04-11
CA2306958C (en) 2007-09-04
AP1182A (en) 2003-06-18
PT1023292E (pt) 2004-02-27
IN184590B (enExample) 2000-09-09
CO4980899A1 (es) 2000-11-27
RS49710B (sr) 2007-12-31
ATE249461T1 (de) 2003-09-15
BG104352A (en) 2001-02-28
KR100543845B1 (ko) 2006-01-23
ID24927A (id) 2000-08-31
TW436488B (en) 2001-05-28
IS5423A (is) 2000-03-28

Similar Documents

Publication Publication Date Title
US20100056770A1 (en) Preparation of nucleosides ribofuranosyl pyrimidines
CN1160354C (zh) 合成氯嘌呤中间体的方法
US8097723B2 (en) Process for the preparation of abacavir
US8183370B2 (en) Process for the preparation of abacavir
US6919449B2 (en) Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
US20020120136A1 (en) Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives
CN101130542B (zh) 抗病毒核苷类似物的合成方法
CN1064683C (zh) 制备嘌呤衍生物的方法
CN1113067C (zh) 新活性肽及其制备
HK1027807B (en) Process for the synthesis of chloropurine intermediates
US7662955B2 (en) Process for the preparation of cefoxitin
US8841467B2 (en) Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
MXPA00003379A (en) Process for the synthesis of chloropurine intermediates
EP0882050A1 (en) Process for preparing purine derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20040804

CX01 Expiry of patent term